D100 LIGELIZUMAB ACHIEVES FAST CONTROL OF SYMPTOMS IN MORE PATIENTS WITH CHRONIC SPONTANEOUS URTICARIA VERSUS OMALIZUMAB
| Autor: | Severin, T., Soong, W., Maurer, M., Giménez-Arnau, A., Hide, M., Bernstein, J., Hua, E., Barve, A., Janocha, R. |
|---|---|
| Zdroj: | In Annals of Allergy, Asthma & Immunology November 2020 125(5) Supplement:S13-S13 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|